Hearing loss is a significant public health problem affecting close to 50 million people in the United States alone. Sensorineural hearing loss is the most common form and is caused by the loss of sensory hair cells in the ...
Jan 9, 2013
16
4
(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung cancer among people ...
Oct 14, 2012
0
0
(HealthDay)—Protease-activated receptor 2 (PAR-2), which is activated by cowhage, may play a role in central centrifugal cicatricial alopecia (CCCA), the most common cause of scarring hair loss in African-American women, ...
Sep 21, 2012
0
0
Scientists working with deaf gerbils said on Wednesday they had found a way of coaxing early stem cells into specialised ear cells that helped the rodents hear sound once more.
Sep 12, 2012
0
0
(AP) -- Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
Jan 30, 2012
0
0
